The AstraZeneca COVID-19 vaccine has been suspended by some European countries after blood clots were reported in some patients who received it. Regulators are now working to determine if those clots were due to the vaccine or just coincidental. Dr. Michelle McMurry-Heath, an immunologist and CEO of the Biotechnology Innovation Organization, explains how the AstraZeneca differs from the other available vaccines and why she believes it will be ruled safe.
After spending weeks hovering around 2% to 3%, Connecticut's COVID-19 test positive rate jumped to nearly 5% on Tuesday, according to the latest data released from the state.
Connecticut's test positivity rate is now 4.96%, up from 2.95% the day before. Of the 17,203 tests administered since Monday, 853 came back positive.
The state's active hospitalizations due to COVID-19 decreased by four while an additional 11 residents lost their lives due to the disease.
Get Connecticut local news, weather forecasts and entertainment stories to your inbox. Sign up for NBC Connecticut newsletters.
Following is the new time frame:
- March 19: Scheduling opens to all individuals between 45 to 54
- April 5 (tentative): Scheduling opens to all individuals age 16 to 44
- The state will work with providers and the Department of Developmental Services to accelerate access for the most medically high-risk individuals under 45 during the month of April.
